ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/22/2026
Back to search
Official data from USPTO
BIOINTERPHASES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/23/2026
Trademark type
Combined
Nice classes
16
Filing date
10/03/2005
Registration date
04/03/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/24/2017
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/07/2006
First use in commerce
09/07/2006
Drawing code
5
Owner type
03
Owner location
New York, NY, US
Examiner
LAPTER, ALAIN J
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
A. S. (pessoa física)
A. S. (pessoa física)
AVS The Science & Technology Society
Representatives
Mark A. Paskar Bryan Cave Leighton Paisner LLP
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Journals in the field of science
Publications
History of USPTO decisions and trademark events.
31 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/03/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/24/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/24/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/24/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/24/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
02/28/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/28/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/03/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/21/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/20/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/20/2012
E815
TEAS SECTION 8 & 15 RECEIVED
04/04/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
04/03/2007
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/12/2007
ALIE
ASSIGNED TO LIE
02/12/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/10/2007
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/09/2007
IUAF
USE AMENDMENT FILED
10/26/2006
PAPER RECEIVED
10/26/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/29/2006
PUBO
PUBLISHED FOR OPPOSITION
06/06/2006
NPUB
NOTICE OF PUBLICATION
05/17/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/17/2006
ALIE
ASSIGNED TO LIE
04/14/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
04/07/2006
GNEA
EXAMINERS AMENDMENT E-MAILED
04/07/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/07/2006
DOCK
ASSIGNED TO EXAMINER
04/06/2006
NWAP
NEW APPLICATION ENTERED
10/06/2005
Continuous trademark protection
Get notified about every new filing that threatens BIOINTERPHASES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.